A cas12a protein mutant with high cleavage activity and application thereof
By mutating the amino acid sequence of the Cas12a protein, its nuclease activity and specificity were improved, solving the problem of insufficient sensitivity of the CRISPR/Cas12a system to single base mismatches and realizing high-sensitivity detection of SNP sites.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- NAT HEALTH COMMISSION INST OF SCI & TECH
- Filing Date
- 2026-02-12
- Publication Date
- 2026-06-23
AI Technical Summary
The CRISPR/Cas12a system has insufficient sensitivity to single base mismatches, especially in SNP detection, where it has limited ability to identify heterozygous samples and cannot effectively distinguish between homozygous and heterozygous sites, thus limiting its application in SNP detection.
By engineering the Cas12a protein, especially by mutating the amino acid sequences of LbCas12a, FnCas12a and GhCas12a, its nuclease activity and specificity are improved, and a nucleic acid detection protein with higher sensitivity and specificity is developed.
This technology enables highly sensitive detection of single-base mismatches, effectively distinguishing between homozygous and heterozygous SNP sites and enhancing the application potential of the CRISPR/Cas12a system in SNP detection.
Smart Images

Figure CN122256305A_ABST